³í¹®) A GLP-1/GLP-2 receptor dual agonist to treat non-alcoholic steatohepatitis: targeting the gut-liver axis and microbiome ¿¬¼¼´ë ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç ÀÌ¿ëÈ£, ÀÇ»ý¸í°úÇкΠ¹è¼öÇÑ ±³¼ö, ¢ß¿¡½º¿¤¸ÞŸÁ¨ °øµ¿ ¿¬±¸ÆÀ